Argos Therapeutics
Argos Therapeutics was a Durham, North Carolina biotechnology company developing personalized dendritic-cell immunotherapies for cancer, infectious diseases and autoimmune diseases using its Arcelis platform. It filed for bankruptcy in 2018, sold substantially all assets in February 2019, and entered liquidation effective September 2019.
Key facts
| CAGE Code | 4JNX5 |
|---|---|
| Company Operating Status | Closed |
| Full Address | 4233 Technology Drive Durham, NC 27704 |
| Previous Name | MERIX BIOSCIENCE INC |
| Wellfound ID | argos-therapeutics |
| Wikidata ID | Q30286762 |